Global Spinal Devices and Biologics Market – Industry Trends and Forecast to 2030

 Spinal Devices and Biologics Market Analysis and Size

The increased use of spinal devices and biologics by surgeons has increased the demand for products that use this technology. As the population ages, so does the prevalence of degenerative devices and age-related spinal deformities, and so does the demand for spinal devices. Vertebrate materials are suitable for bone fusion surgery, spinal cord injury, and degenerative disc disease. The spine treatment market was 75% traditional metal rods and plates and 25% biological products ten years ago.

Data Bridge Market Research analyses that the spinal devices and biologics market which is USD 8478.94 million in 2022, is expected to reach USD 29773.40 million by 2030, at a CAGR of 17.00% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Spinal Devices and Biologics Market Scope and Segmentation  

Market Definition

Biological substances actively alter the environment and cause changes to occur as a result of biological processes. The use of bone replacement materials, and growing awareness of the ageing population, bio pharmacy is becoming an increasingly important component for spinal fusion because of its potential impact. Spinal implants are commonly used in spinal surgery to treat complications such as deformities, disc degeneration, and fractures. In contrast to inactive metals, which do not alter cell function or stimulate cell growth, they actively promote bone formation and spinal fusion.

Spinal Devices and Biologics Market Dynamics

Drivers

• Increasing demand for a number of spinal surgeries

The rise in spinal diseases has resulted in an increase in spinal surgeries, which has increased the demand for spinal devices. The most common reason for spinal surgeries is to treat degenerative disc disease and birth deformities. In the forecast period, the growing number of minimally invasive surgeries will drive the growth of the spinal devices and biologics market.

• Launch of new products for increasing adoption of spinal devices

Several technological advancements in the spinal devices industry aided in the discovery of several orthopaedic implants that will better treat patients with spinal diseases. The primary manufacturers in this sector are focusing on minimally invasive solutions and customised implants, which will boost market growth even further. Furthermore, strategic collaborations among several manufacturers resulted in the discovery of novel technologies and solutions for spinal surgeries.

Opportunities

• Rise in the elderly population and associated comorbidities

The growing elderly population and associated comorbidities are primarily driving market growth opportunities. The ageing population's obesity, combined with an increas​​​​​​​e in the number of spine deformities, is expected to fuel the growth of the spinal devices and biologics industry. All of these conditions tend to use minimally invasive surgeries, which will help the market grow.

Restraints/Challenges

• High prices and unbalanced compensation policies

High prices and unbalanced compensation policies can stifle company growth in this market. To be a revenue generation pioneer, companies doing business in this field must explain science with their products. Companies must understand their customers' current needs and be able to incorporate the latest innovations into their products. It aids them in increasing their sales. Companies in this market must understand the significance of global awareness campaigns for these devices.

This spinal devices and biologics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the spinal devices and biologics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In 2021, Spine Wave announced the launch of the Ticell 3D advanced surface technology and the stronghold 3D Titanium Interbody Device. This latest innovation will aid the company's growth by complementing its innovative products.
• In 2021, Osseus Fusion Systems announced the release of the Aries-TC. It is a transforaminal curved interbody fusion device printed in 3D. This new device can help skeletally strong patients who have a degenerative device.

Global Spinal Devices and Biologics Market Scope

The spinal devices and biologics market is segmented on the basis of type, disease indication and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Fusion Devices
• Cervical
• Thoracolumbar
• Interbody
• Biologics
• Non-fusion devices
• Vertebral compression fracture devices
• Artificial discs
• Dynamic stabilization devices
• Others

Disease Indication

• Degenerative Disc Disease
• Complex Deformity
• Traumas and Fractures
• Others

End User

• Hospitals and Ambulatory Surgery Centers
• Specialty Clinics
• Others

Spinal Devices and Biologics Market Regional Analysis/Insights

The spinal devices and biologics market is analyzed and market size insights and trends are provided by country, type, disease indication and end user as referenced above.

The countries covered in the spinal devices and biologics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the spinal devices and biologics market as a result of the rise in spinal illness patients. New product releases, strategic alliances, expanded biologics research, and the rising incidence of spinal disorders are further major drivers of the market for spinal devices and biologics' dominance.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 because to rising health care expenses, a big patient population, rising income levels, and increased government support for and knowledge of these technologies.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The spinal devices and biologics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for spinal devices and biologics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the spinal devices and biologics market. The data is available for historic period 2011-2021.

Competitive Landscape and Spinal Devices and Biologics Market Share Analysis

The spinal devices and biologics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to spinal devices and biologics market.

Some of the major players operating in the spinal devices and biologics market are:

• Exactech, Inc., (U.S.)
• Zimmer Biomet (U.S.)
• Medtronic (Ireland)
• Globus Medical (U.S.)
• Integra LifeSciences (U.S.)
• NuVasive, Inc., (U.S.)
• Stryker (U.S.)
• Orthofix US LLC (U.S.)
• Wright Medical Group N.V. (U.S.)
• Smith+Nephew (U.K.)
• ZAVATION (U.S.)

SKU-68963